drugset / Trial / NCT02784392
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effect Ulimorelin in patients with enteral feeding intolerance.
Timeline
- Start
- 2016-10
- Primary completion
- 2018-03
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metoclopramide | Small molecule | — | — |
| Subject | Ulimorelin | Small molecule | — | Intravenous |
Indications
No indication recorded.